ClariVest Asset Management’s Avanos Medical AVNS Stock Holding History

ClariVest Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$538	Hold	27	–	–	﹤0.01%	765
2024 Q2	$538	Hold	27	–	–	﹤0.01%	765
2024 Q1	$538	Hold	27	–	–	﹤0.01%	782
2023 Q4	$606	Hold	27	–	–	﹤0.01%	778
2023 Q3	$1K	Sell	27 -54,679	-100%	-$1.24M	﹤0.01%	570
2023 Q2	$1.4M	Buy	54,706 +1,657	+3%	+$43.6K	0.07%	178
2023 Q1	$1.58M	Sell	53,049 -9,549	-15%	-$277K	0.07%	202
2022 Q4	$1.69M	Sell	62,598 -471	-0.7%	-$11.5K	0.08%	186
2022 Q3	$1.38M	Sell	63,069 -121	-0.2%	-$3.16K	0.07%	221
2022 Q2	$1.73M	Buy	63,190 +18,500	+41%	+$532K	0.08%	208
2022 Q1	$1.5M	Buy	+44,690	New	+$1.44M	0.06%	242
2018 Q4	–	Sell	-15	Closed	-$1K	–	696
2018 Q3	$1K	Buy	+15	New	+$965	﹤0.01%	675
2017 Q1	–	Sell	-23,100	Closed	-$854K	–	683
2016 Q4	$854K	Buy	23,100 +9,800	+74%	+$350K	0.02%	357
2016 Q3	$461K	Buy	+13,300	New	+$466K	0.01%	383

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

ClariVest Asset Management's AVNS Position: Q3 2024 in Review

ClariVest Asset Management held its Avanos Medical (AVNS) position steady in Q3 2024 at 27 shares worth $538. The position accounts for ﹤0.01% of the portfolio, ranked #765.

ClariVest Asset Management first reported a position in AVNS in Q3 2016 and has held it in 14 quarters since. The position peaked at $1.73M in Q2 2022. 260 funds tracked by Wall St. Rank hold AVNS as of Q3 2024.

ClariVest Asset Management held 27 shares of Avanos Medical worth $538 as of Q3 2024.
ClariVest Asset Management left its Avanos Medical share count unchanged in Q3 2024.
Avanos Medical made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #765 holding.
ClariVest Asset Management first reported a position in Avanos Medical in Q3 2016 and has held it in 14 quarters since.
ClariVest Asset Management's Avanos Medical position peaked at $1.73M in Q2 2022.
260 funds tracked by Wall St. Rank held Avanos Medical as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.